CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-01 | Smith Martin Alexander Executive Vice President | Shares withheld for taxes | −6 | $349.93 | $2K | 43 |
| 2022-09-01 | Smith Martin Alexander Executive Vice President | Exercise or conversion · Restricted Stock Unit | −19 | 1,241 | ||
| 2022-08-05 | AYERS JONATHAN W Director | Gift | −5,000 | 625,420 | ||
| 2022-08-05 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +192 | 28,365.64 | ||
| 2022-08-05 | MCKEON BRIAN P Executive VP & CFO | Shares withheld for taxes | −90 | $407.78 | $37K | 28,275.64 |
| 2022-08-05 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion · Restricted Stock Unit | −192 | 4,593 | ||
| 2022-08-05 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion | +385 | 51,696.64 | ||
| 2022-08-05 | MAZELSKY JONATHAN JAY President & CEO | Shares withheld for taxes | −179 | $407.78 | $73K | 51,517.64 |
| 2022-08-05 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion · Restricted Stock Unit | −385 | 9,990 | ||
| 2022-07-29 | JUNIUS DANIEL M Director | Grant or award | +16 | $399.18 | $6K | 2,950 |
| 2022-06-01 | Johnson Michael Perkins Senior Vice President | Grant or award · Restricted Stock Unit | +3,382 | 3,382 | ||
| 2022-05-20 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion | +706 | $141.60 | $100K | 51,300.64 |
| 2022-05-20 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2022-05-11 | SAMAD SAM Director | Grant or award · Deferred Stock Unit | +344 | 344 | ||
| 2022-05-11 | SAMAD SAM Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +945 | 945 | ||
| 2022-05-11 | Claflin Bruce L. Director | Grant or award · Deferred Stock Unit | +344 | 344 | ||
| 2022-05-11 | Claflin Bruce L. Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +945 | 945 | ||
| 2022-05-11 | Vandebroek Sophie V. Director | Exercise or conversion | +224 | 872 | ||
| 2022-05-11 | Vandebroek Sophie V. Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +945 | 945 | ||
| 2022-05-11 | Vandebroek Sophie V. Director | Grant or award · Restricted Stock Unit | +344 | 568 |
Page 54 of 74 · 1,474 trades